Controversies in drug allergy: In vitro testing

Journal of Allergy and Clinical Immunology - Tập 143 - Trang 56-65 - 2019
Cristobalina Mayorga1,2, Didier G. Ebo3, David M. Lang4, Werner J. Pichler5, Vito Sabato3, Miguel A. Park6, Joanna Makowska7, Marina Atanaskovic-Markovic8, Patrizia Bonadonna9, Edgardo Jares10
1Research Laboratory, IBIMA-Regional University Hospital of Malaga-UMA, ARADyAL, Malaga, Spain
2Allergy Unit, IBIMA-Regional University Hospital of Malaga-UMA, ARADyAL, Malaga, Spain
3Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium
4Department of Allergy and Clinical Immunology Respiratory Institute Cleveland Clinic, Cleveland, Ohio
5ADR-AC GmbH, Bern, Switzerland
6Division of Allergic Diseases, Mayo Clinic, Rochester, Minn
7Department of Rheumatology, Medical University of Lodz, Poland
8Faculty of Medicine, University of Belgrade, University Children`s Hospital, Belgrade, Serbia
9Allergy Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
10Libra Foundation, Buenos Aires, Argentina

Tài liệu tham khảo

Demoly, 2014, International consensus on drug allergy, Allergy, 69, 420, 10.1111/all.12350 Brockow, 2013, Skin test concentrations for systemically administered drugs—an ENDA/EAACI Drug Allergy Interest Group position paper, Allergy, 68, 702, 10.1111/all.12142 Uyttebroek, 2015, Moxifloxacin hypersensitivity: uselessness of skin testing, J Allergy Clin Immunol Pract, 3, 443, 10.1016/j.jaip.2014.12.012 Aberer, 2003, Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations, Allergy, 58, 854, 10.1034/j.1398-9995.2003.00279.x Torres, 2017, Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America, Clin Transl Allergy, 7, 7, 10.1186/s13601-017-0144-0 Brozek, 2009, Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies, Allergy, 64, 1109, 10.1111/j.1398-9995.2009.02083.x Blanca, 2009, Update on the evaluation of hypersensitivity reactions to betalactams, Allergy, 64, 183, 10.1111/j.1398-9995.2008.01924.x Pichler, 2016, Classification of Drug hypersensitivity into allergic, p-i, and pseudo-allergic forms, Int Arch Allergy Immunol, 171, 166, 10.1159/000453265 Mayorga, 2016, In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper, Allergy, 71, 1103, 10.1111/all.12886 Szczeklik, 2003, Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management, J Allergy Clin Immunol, 111, 913, 10.1067/mai.2003.1487 Kowalski, 2013, Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs, Allergy, 68, 1219, 10.1111/all.12260 Spoerl, 2016, Non-IgE-dependent hypersensitivity to rocuronium reversed by sugammadex: report of three cases and hypothesis on the underlying mechanism, Int Arch Allergy Immunol, 169, 256, 10.1159/000446182 McNeil, 2015, Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions, Nature, 519, 237, 10.1038/nature14022 Ebo, 2018, In vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature, J Allergy Clin Immunol Pract, 6, 1176, 10.1016/j.jaip.2018.01.004 Pichler, 2015, Drug hypersensitivity: how drugs stimulate T cells via pharmacological interaction with immune receptors, Int Arch Allergy Immunol, 168, 13, 10.1159/000441280 Schrijvers, 2015, Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back, Clin Transl Allergy, 5, 31, 10.1186/s13601-015-0073-8 Ebo, 2011, The in vitro diagnosis of drug allergy: status and perspectives, Allergy, 66, 1275, 10.1111/j.1398-9995.2011.02661.x Decuyper, 2017, In vitro diagnosis of immediate drug hypersensitivity anno 2017: potentials and limitations, Drugs R D, 17, 265, 10.1007/s40268-017-0176-x Sanz, 2010, In vitro diagnosis of anaphylaxis, Chem Immunol Allergy, 95, 125, 10.1159/000315947 Mertes, 2003, Alla F, Groupe d'Etudes des Reactions Anaphylactoides P. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000, Anesthesiology, 99, 536, 10.1097/00000542-200309000-00007 Dybendal, 2003, Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia, Acta Anaesthesiol Scand, 47, 1211, 10.1046/j.1399-6576.2003.00237.x Berroa, 2014, The usefulness of plasma histamine and different tryptase cut-off points in the diagnosis of peranaesthetic hypersensitivity reactions, Clin Exp Allergy, 44, 270, 10.1111/cea.12237 Komericki, 2006, Tryptase as severity marker in drug provocation tests, Int Arch Allergy Immunol, 140, 164, 10.1159/000092556 Sala-Cunill, 2013, Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients, Int Arch Allergy Immunol, 160, 192, 10.1159/000339749 Baretto, 2017, Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective, Allergy, 72, 2031, 10.1111/all.13226 Bochenek, 2018, Diagnostic accuracy of urinary LTE4 measurement to predict aspirin-exacerbated respiratory disease in patients with asthma, J Allergy Clin Immunol Pract, 6, 528, 10.1016/j.jaip.2017.07.001 Mayorga, 2017, The value of in vitro tests to diminish drug challenges, Int J Mol Sci, 18, 10.3390/ijms18061222 Vultaggio, 2015, High serum beta-lactams specific/total IgE ratio is associated with immediate reactions to beta-lactams antibiotics, PLoS One, 10, e0121857, 10.1371/journal.pone.0121857 Vultaggio, 2010, Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions, Allergy, 65, 657, 10.1111/j.1398-9995.2009.02280.x Torres, 2001, Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing, Allergy, 56, 850, 10.1034/j.1398-9995.2001.00089.x Fontaine, 2007, Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy, Allergy, 62, 47, 10.1111/j.1398-9995.2006.01268.x Blanca, 2001, Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy, Allergy, 56, 862, 10.1034/j.1398-9995.2001.00995.x Rouzaire, 2012, IgE antibody detection in the diagnosis of hypersensitivity to neuromuscular blocking agents, Acta Anaesthesiol Scand, 56, 263, 10.1111/j.1399-6576.2011.02540.x Monneret, 2002, Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs, Clin Immunol, 102, 192, 10.1006/clim.2001.5156 Mata, 1992, Clinical evaluation of in vitro leukocyte histamine release in allergy to muscle relaxant drugs, Allergy, 47, 471, 10.1111/j.1398-9995.1992.tb00667.x Leysen, 2011, Allergy to rocuronium: from clinical suspicion to correct diagnosis, Allergy, 66, 1014, 10.1111/j.1398-9995.2011.02569.x Laroche, 2011, Evaluation of a new routine diagnostic test for immunoglobulin e sensitization to neuromuscular blocking agents, Anesthesiology, 114, 91, 10.1097/ALN.0b013e31820164d2 Ebo, 2007, Immunoglobulin E antibodies to rocuronium: a new diagnostic tool, Anesthesiology, 107, 253, 10.1097/01.anes.0000270735.40872.f2 Matucci, 2013, Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab, Clin Exp Allergy, 43, 659 Chung, 2008, Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose, N Engl J Med, 358, 1109, 10.1056/NEJMoa074943 Caiado, 2013, Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy, J Allergy Clin Immunol Pract, 1, 494, 10.1016/j.jaip.2013.06.002 Torres, 2010, Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions, J Allergy Clin Immunol, 125, 502, 10.1016/j.jaci.2009.11.032 Salas, 2017, Patients taking amoxicillin-clavulanic can become simultaneously sensitized to both drugs, J Allergy Clin Immunol Pract, 5, 694, 10.1016/j.jaip.2017.02.007 Salas, 2018, Use of the basophil activation test may reduce the need for drug provocation in amoxicillin-clavulanic allergy, J Allergy Clin Immunol Pract, 6, 1010, 10.1016/j.jaip.2017.08.009 Leysen, 2014, Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need, Clin Exp Allergy, 44, 1069, 10.1111/cea.12344 Uyttebroek, 2014, In vitro diagnosis of immediate IgE-mediated drug hypersensitivity: warnings and (unmet) needs, Immunol Allergy Clin North Am, 34, 681, 10.1016/j.iac.2014.04.007 Torres, 2004, The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams, Clin Exp Allergy, 34, 1768, 10.1111/j.1365-2222.2004.02110.x Sanz, 2002, Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics, Clin Exp Allergy, 32, 277, 10.1046/j.1365-2222.2002.01305.x Sanchez-Morillas, 2010, Selective allergic reactions to clavulanic acid: a report of 9 cases, J Allergy Clin Immunol, 126, 177, 10.1016/j.jaci.2010.03.012 Eberlein, 2010, A new basophil activation test using CD63 and CCR3 in allergy to antibiotics, Clin Exp Allergy, 40, 411, 10.1111/j.1365-2222.2009.03426.x De Weck, 2009, Diagnosis of immediate-type β-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study, J Investig Allergol Clin Immunol, 19, 91 Abuaf, 2012, Comparison of CD63 upregulation induced by NSAIDs on basophils and monocytes in patients with NSAID hypersensitivity, J Allergy (Cairo), 2012, 580873 Uyttebroek, 2014, Flowcytometric diagnosis of atracurium-induced anaphylaxis, Allergy, 69, 1324, 10.1111/all.12468 Sudheer, 2005, Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c, Anaesthesia, 60, 251, 10.1111/j.1365-2044.2004.04086.x Kvedariene, 2006, Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils, Allergy, 61, 311, 10.1111/j.1398-9995.2006.00978.x Hagau, 2013, Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions, Allergy Asthma Clin Immunol, 9, 42, 10.1186/1710-1492-9-42 Ebo, 2006, Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide, Allergy, 61, 935, 10.1111/j.1398-9995.2006.01094.x Abuaf, 1999, Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy, J Allergy Clin Immunol, 104, 411, 10.1016/S0091-6749(99)70386-6 Hagau, 2013, Threshold for positivity and optimal dipyrone concentration in flow cytometry-assisted basophil activation test, Allergy Asthma Immunol Res, 5, 383, 10.4168/aair.2013.5.6.383 Gomez, 2009, Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients, Clin Exp Allergy, 39, 1217, 10.1111/j.1365-2222.2009.03237.x Gamboa, 2003, Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients, Allergy, 58, 312, 10.1034/j.1398-9995.2003.00096.x Rouzaire, 2012, Negativity of the basophil activation test in quinolone hypersensitivity: a breakthrough for provocation test decision-making, Int Arch Allergy Immunol, 157, 299, 10.1159/000328211 Mayorga, 2013, Fluoroquinolone photodegradation influences specific basophil activation, Int Arch Allergy Immunol, 160, 377, 10.1159/000343023 Fernandez, 2016, Hypersensitivity to fluoroquinolones: the expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone, Medicine (Baltimore), 95, e3679, 10.1097/MD.0000000000003679 Aranda, 2011, In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones, Allergy, 66, 247, 10.1111/j.1398-9995.2010.02460.x Salas, 2013, Diagnosis of immediate hypersensitivity reactions to radiocontrast media, Allergy, 68, 1203 Pinnobphun, 2011, The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media, Ann Allergy Asthma Immunol, 106, 387, 10.1016/j.anai.2010.12.020 Giavina-Bianchi, 2017, Basophil activation test is a relevant biomarker of the outcome of rapid desensitization in platinum compounds-allergy, J Allergy Clin Immunol Pract, 5, 728, 10.1016/j.jaip.2016.11.006 Garvey, 2007, IgE-mediated allergy to chlorhexidine, J Allergy Clin Immunol, 120, 409, 10.1016/j.jaci.2007.04.029 Laguna, 2018, The basophil activation test can be of value for diagnosing immediate allergic reactions to omeprazole, J Allergy Clin Immunol Pract, 6, 1628, 10.1016/j.jaip.2017.12.001 MacGlashan, 2010, Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes, Clin Exp Allergy, 40, 1365, 10.1111/j.1365-2222.2010.03572.x Knol, 1991, Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways, Eur J Immunol, 21, 881, 10.1002/eji.1830210404 Hoffmann, 2015, The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease, Allergy, 70, 1393, 10.1111/all.12698 Ariza, 2016, Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole, Sci Rep, 6, 23845, 10.1038/srep23845 Leysen, 2013, IgE-mediated allergy to pholcodine and cross-reactivity to neuromuscular blocking agents: lessons from flow cytometry, Cytometry B Clin Cytom, 84, 65, 10.1002/cyto.b.21074 Van Gasse, 2017, Immediate moxifloxacin hypersensitivity: is there more than currently meets the eye?, Allergy, 72, 2039, 10.1111/all.13236 Sanz, 2005, A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs, Int Arch Allergy Immunol, 136, 58, 10.1159/000082586 Rodriguez-Trabado, 2008, Basophil activation test for the in vitro diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity, Allergy Asthma Proc, 29, 241, 10.2500/aap.2008.29.3114 Bavbek, 2009, Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance, Int Arch Allergy Immunol, 150, 261, 10.1159/000222678 Ariza, 2014, Basophil activation after nonsteroidal anti-inflammatory drugs stimulation in patients with immediate hypersensitivity reactions to these drugs, Cytometry A, 85, 400, 10.1002/cyto.a.22443 Korosec, 2011, Acetylsalicylic acid-triggered 15-HETE generation by peripheral leukocytes for identifying ASA sensitivity, Respir Med, 105, S81, 10.1016/S0954-6111(11)70017-8 Bavbek, 2009, Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivity, Int Arch Allergy Immunol, 149, 58, 10.1159/000176307 Kepley, 1999, Syk deficiency in nonreleaser basophils, J Allergy Clin Immunol, 104, 279, 10.1016/S0091-6749(99)70367-2 Knol, 1992, Intracellular events in anti-IgE nonreleasing human basophils, J Allergy Clin Immunol, 90, 92, 10.1016/S0091-6749(06)80015-1 Rozieres, 2009, Detection and quantification of drug-specific T cells in penicillin allergy, Allergy, 64, 534, 10.1111/j.1398-9995.2008.01674.x Rodriguez-Pena, 2006, Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams, J Allergy Clin Immunol, 118, 949, 10.1016/j.jaci.2006.07.013 Orasch, 1999, T-cell reaction to local anaesthetics: relationship to angioedema and urticaria after subcutaneous application—patch testing and LTT in patients with adverse reaction to local anaesthetics, Clin Exp Allergy, 29, 1549, 10.1046/j.1365-2222.1999.00693.x Luque, 2001, In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions, Allergy, 56, 611, 10.1034/j.1398-9995.2001.000115.x Sachs, 2002, Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization, Clin Exp Allergy, 32, 736, 10.1046/j.1365-2222.2002.01382.x Roujeau, 1985, Lymphocyte transformation test in drug-induced toxic epidermal necrolysis, Int Arch Allergy Appl Immunol, 78, 22, 10.1159/000233856 Porebski, 2013, In vitro drug causality assessment in Stevens-Johnson syndrome—alternatives for lymphocyte transformation test, Clin Exp Allergy, 43, 1027, 10.1111/cea.12145 Polak, 2013, In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions, Br J Dermatol, 168, 539, 10.1111/bjd.12109 Karami, 2016, Evaluation of lymphocyte transformation test results in patients with delayed hypersensitivity reactions following the use of anticonvulsant drugs, Int Arch Allergy Immunol, 170, 158, 10.1159/000448284 Kano, 2007, Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption, Allergy, 62, 1439, 10.1111/j.1398-9995.2007.01553.x Houwerzijl, 1977, Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity, Clin Exp Immunol, 29, 272 Hanafusa, 2012, The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity, J Dermatol Sci, 65, 213, 10.1016/j.jdermsci.2011.12.002 Hirata, 2009, Lymphocyte transformation test is not helpful for the diagnosis of methotrexate-induced pneumonitis in patients with rheumatoid arthritis, Clin Chim Acta, 407, 25, 10.1016/j.cca.2009.06.024 Johnston, 1988, The effect of in vivo and in vitro methotrexate on lymphocyte proliferation as measured by the uptake of tritiated thymidine and tritiated guanosine, Clin Exp Rheumatol, 6, 391 Zawodniak, 2010, In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases, Allergy, 65, 376, 10.1111/j.1398-9995.2009.02180.x Porebski, 2017, In vitro assays in severe cutaneous adverse drug reactions: are they still research tools or diagnostic tests already?, Int J Mol Sci, 18, 10.3390/ijms18081737 Porebski, 2011, In vitro diagnosis of T cell-mediated drug allergy, Clin Exp Allergy, 41, 461, 10.1111/j.1365-2222.2011.03701.x Lochmatter, 2009, Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity, Allergy, 64, 1269, 10.1111/j.1398-9995.2009.01985.x Phillips, 2011, Drug hypersensitivity: pharmacogenetics and clinical syndromes, J Allergy Clin Immunol, 127, S60, 10.1016/j.jaci.2010.11.046 Mallal, 2008, HLA-B*5701 screening for hypersensitivity to abacavir, N Engl J Med, 358, 568, 10.1056/NEJMoa0706135 Colombo, 2008, The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir, J Infect Dis, 198, 864, 10.1086/591184 Tangamornsuksan, 2013, Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis, JAMA Dermatol, 149, 1025, 10.1001/jamadermatol.2013.4114 Mehta, 2009, Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians, Indian J Dermatol Venereol Leprol, 75, 579, 10.4103/0378-6323.57718 Locharernkul, 2008, Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population, Epilepsia, 49, 2087, 10.1111/j.1528-1167.2008.01719.x Chung, 2004, Medical genetics: a marker for Stevens-Johnson syndrome, Nature, 428, 486, 10.1038/428486a Genin, 2014, HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis, Pharmacogenomics J, 14, 281, 10.1038/tpj.2013.40 Pirmohamed, 2015, New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity, J Allergy Clin Immunol, 136, 236, 10.1016/j.jaci.2015.06.022 Tangamornsuksan, 2018, Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis, JAMA Dermatol, 154, 441, 10.1001/jamadermatol.2017.6484 Cai, 2018, Dapsone-induced drug reaction with eosinophilia and systemic symptoms associated with HLA-B*13:01, Intern Med J, 48, 363, 10.1111/imj.13730 Zhang, 2013, HLA-B*13:01 and the dapsone hypersensitivity syndrome, N Engl J Med, 369, 1620, 10.1056/NEJMoa1213096 Lonjou, 2008, A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs, Pharmacogenet Genomics, 18, 99, 10.1097/FPC.0b013e3282f3ef9c Hung, 2005, HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol, Proc Natl Acad Sci U S A, 102, 4134, 10.1073/pnas.0409500102 Lee, 2012, Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?, Intern Med J, 42, 411, 10.1111/j.1445-5994.2011.02567.x 2000, The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters, Ann Allergy Asthma Immunol, 85, 521 Macy, 2010, Use of commercial anti-penicillin IgE fluorometric enzyme immunoassays to diagnose penicillin allergy, Ann Allergy Asthma Immunol, 105, 136, 10.1016/j.anai.2010.06.014 Johansson, 2013, False-positive penicillin immunoassay: an unnoticed common problem, J Allergy Clin Immunol, 132, 235, 10.1016/j.jaci.2012.11.017 Vultaggio, 2009, Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies, Clin Exp Allergy, 39, 838, 10.1111/j.1365-2222.2009.03219.x 2010, Drug allergy: an updated practice parameter, Ann Allergy Asthma Immunol, 105, 259, 10.1016/j.anai.2010.08.002 Celik, 2009, Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease, Clin Exp Allergy, 39, 1522, 10.1111/j.1365-2222.2009.03277.x Opstrup, 2014, Standardized testing with chlorhexidine in perioperative allergy—a large single-centre evaluation, Allergy, 69, 1390, 10.1111/all.12466 Harboe, 2005, Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study, Anesthesiology, 102, 897, 10.1097/00000542-200505000-00006 Manfredi, 2004, Detection of specific IgE to quinolones, J Allergy Clin Immunol, 113, 155, 10.1016/j.jaci.2003.09.035 Iwamoto, 2012, Evaluation of basophil CD203c as a predictor of carboplatin-related hypersensitivity reaction in patients with gynecologic cancer, Biol Pharm Bull, 35, 1487, 10.1248/bpb.b12-00150 Ariza, 2016, The influence of the carrier molecule on amoxicillin recognition by specific IgE in patients with immediate hypersensitivity reactions to betalactams, Sci Rep, 6, 35113, 10.1038/srep35113 Elsheikh, 2011, Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis, J Allergy Clin Immunol, 127, 1543, 10.1016/j.jaci.2010.12.1119 Chung, 2008, Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis, Nat Med, 14, 1343, 10.1038/nm.1884 Sanchez-Quintero, 2013, Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients, PLoS One, 8, e74198, 10.1371/journal.pone.0074198 Lopez, 2009, Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins, Br J Dermatol, 160, 259, 10.1111/j.1365-2133.2008.08875.x Antunez, 2011, Recognition of iodixanol by dendritic cells increases the cellular response in delayed allergic reactions to contrast media, Clin Exp Allergy, 41, 657, 10.1111/j.1365-2222.2010.03693.x